Meeting of the Secretary's Advisory Committee on Human Research Protections, 36783-36784 [2013-14518]

Download as PDF 36783 Federal Register / Vol. 78, No. 118 / Wednesday, June 19, 2013 / Notices TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS Number of respondents Form name Number of responses per respondent Average burden per response (in hours) Total burden hours Primary Care .................................................................................................... Specialists ........................................................................................................ 120 480 1 1 20/60 20/60 40 160 Total .......................................................................................................... 600 600 200 200 Darius Taylor, Deputy Information Collection Clearance Officer. [FR Doc. 2013–14591 Filed 6–18–13; 8:45 am] BILLING CODE 4150–05–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Advisory Committee on Minority Health Office of Minority Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice of meeting. AGENCY: SUMMARY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (DHHS) is hereby giving notice that the Advisory Committee on Minority Health (ACMH) will hold a meeting. This meeting will be open to the public. Preregistration is required for both public attendance and comment. Any individual who wishes to attend the meetings and/or participate in the public comment session should email acmh@osophs.dhhs.gov. The meeting will be held on Tuesday, July 9, 2013, from 9:00 a.m. to 5:00 p.m. (EST) and Wednesday, July 10, 2013, from 9:00 a.m. to 1:00 p.m. (EST). DATES: The meeting will be held at the Doubletree Hotel, 1515 Rhode Island Avenue NW., Washington, DC 20005. FOR FURTHER INFORMATION CONTACT: Ms. Monica A. Baltimore, Tower Building, 1101 Wootton Parkway, Suite 600, Rockville, Maryland 20852. Phone: 240– 453–2882, Fax: 240–453–2883. SUPPLEMENTARY INFORMATION: In accordance with Public Law 105–392, the ACMH was established to provide advice to the Deputy Assistant Secretary for Minority Health in improving the health of each racial and ethnic minority group and on the development of goals and specific program activities of the Office of Minority Health. Topics to be discussed during these meetings will include strategies to mstockstill on DSK4VPTVN1PROD with NOTICES ADDRESSES: VerDate Mar<15>2010 17:13 Jun 18, 2013 Jkt 229001 improve the health of racial and ethnic minority populations through the development of health policies and programs that will help eliminate health disparities. Public attendance at this meeting is limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the designated contact person at least fourteen (14) business days prior to the meeting. Members of the public will have an opportunity to provide comments at the meeting. Public comments will be limited to three minutes per speaker. Individuals who would like to submit written statements should mail or fax their comments to the Office of Minority Health at least seven (7) business days prior to the meeting. Any members of the public who wish to have printed material distributed to ACMH committee members should submit their materials to the Executive Director, ACMH, Tower Building, 1101 Wootton Parkway, Suite 600, Rockville, Maryland 20852, prior to close of business Monday, July 1, 2013. Dated: June 10, 2013. Monica A. Baltimore, Executive Director, Advisory Committee on Minority Health, Office of Minority Health, U.S. Department of Health and Human Services. [FR Doc. 2013–14520 Filed 6–18–13; 8:45 am] BILLING CODE 4150–29–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Secretary’s Advisory Committee on Human Research Protections Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: SUMMARY: Pursuant to Section 10(a) of the Federal Advisory Committee Act, U.S.C. Appendix 2, notice is hereby given that the Secretary’s Advisory PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 Committee on Human Research Protections (SACHRP) will hold a meeting that will be open to the public. Information about SACHRP and the full meeting agenda will be posted on the SACHRP Web site at: https:// www.dhhs.gov/ohrp/sachrp/mtgings/ index.html. DATES: The meeting will be held on Wednesday, July 10, 2013 from 8:30 a.m. until 5:00 p.m. and Thursday, July 11, 2013 from 8:30 a.m. until 4:30 p.m. ADDRESSES: U.S. Department of Health and Human Services, 200 Independence Avenue SW., Hubert H. Humphrey Building, Room 800, Washington, DC 20201. Jerry Menikoff, M.D., J.D., Director, Office for Human Research Protections (OHRP), or Julia Gorey, J.D., Executive Director, SACHRP; U.S. Department of Health and Human Services, 1101 Wootton Parkway, Suite 200, Rockville, Maryland 20852; 240–453–8141; fax: 240–453–6909; email address: Julia.Gorey@hhs.gov. FOR FUTHER INFORMATION CONTACT: Under the authority of 42 U.S.C. 217a, Section 222 of the Public Health Service Act, as amended, SACHRP was established to provide expert advice and recommendations to the Secretary of Health and Human Services through the Assistant Secretary for Health, on issues and topics pertaining to or associated with the protection of human research subjects. The meeting will open to the public at 8:30 a.m., Wednesday, July 10. Following opening remarks from Dr. Jerry Menikoff, OHRP Director, and Dr. Jeffrey Botkin, SACHRP Chair, the Subcommittee on Harmonization (SOH) will give their report. SOH was established by SACHRP at its July 2009 meeting and is charged with identifying and prioritizing areas in which regulations and/or guidelines for human subjects research adopted by various agencies or offices within HHS would benefit from harmonization, consistency, clarity, simplification and/ or coordination. The SOH report will be followed by an expert panel discussion SUPPLEMENTARY INFORMATION: E:\FR\FM\19JNN1.SGM 19JNN1 36784 Federal Register / Vol. 78, No. 118 / Wednesday, June 19, 2013 / Notices of informed consent issues in cluster randomized trials. After lunch, there will be a special expert panel discussing Certificates of Confidentiality (COCs). Following opening remarks on the morning of July 11, the Subpart A Subcommittee (SAS) will give their report. This will be followed by a discussion of the concept of engagement in human subjects research. SAS is charged with developing recommendations for consideration by SACHRP regarding the application of subpart A of 45 CFR part 46 in the current research environment; this Subcommittee was established by SACHRP in October 2006. The day will conclude with a panel discussion of issues surrounding electronic informed consent. Public attendance at the meeting is limited to space available. Individuals who plan to attend the meeting and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the designated contact persons. Members of the public will have the opportunity to provide comments on both days of the meeting. Public comment will be limited to five minutes per speaker. Any members of the public who wish to have printed materials distributed to SACHRP members for this scheduled meeting should submit materials to the Executive Director, SACHRP, prior to the close of business July 5, 2013. Dated: June 12, 2013. Jerry Menikoff, Director, Office for Human Research Protections, Executive Secretary, Secretary’s Advisory Committee on Human Research Protections. [FR Doc. 2013–14518 Filed 6–18–13; 8:45 am] BILLING CODE 4150–36–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention (CDC) [CDC–2013–0010, Docket Number NIOSH– 265] mstockstill on DSK4VPTVN1PROD with NOTICES Survey of Nanomaterial Risk Management Practices National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Proposed NIOSH Survey of Nanomaterial Risk Management AGENCY: VerDate Mar<15>2010 17:13 Jun 18, 2013 Jkt 229001 Practices; Notice of Public Meeting and Request for Comments. SUMMARY: The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) announces a public meeting and opportunity for comment on a proposed NIOSH survey. The primary purpose of the survey is to evaluate the use of NIOSH guidelines and risk mitigation practices for safe handling of engineered nanomaterials (ENMs) in the workplace. Information collected from the survey will be useful in future revisions of the guidelines. The public is invited to comment on the proposed survey through a public docket and/or participation in a one-day public meeting. To view the notice and related materials, visit https:// www.regulations.gov and enter CDC– 2013–0010 in the search field and click ‘‘Search.’’ Public comment period: Submit either electronic or written comments by September 15, 2013. Registration to attend the meeting must be received by July 17, 2013 and will be accepted on a first come first served basis. See the SUPPLEMENTARY INFORMATION section for information on how to register for the meeting. ADDRESSES: The public meeting will be held at the NIOSH Alice Hamilton building, 5555 Ridge Avenue, Cincinnati, OH 45213. The public meeting will be held on July 31, 2013, from 8 a.m. to 3:00 p.m. EDT. Security Considerations: Due to mandatory security clearance procedures at the NIOSH Alice Hamilton building, in-person attendees must present valid government-issued picture identification to security personnel upon entering the parking lot. Non-U.S. citizens: Because of CDC Security Regulations, any non-U.S. citizen wishing to attend this meeting must provide the following information in writing to the NIOSH Docket Officer at the address below no later than June 29, 2013 to allow time for mandatory CDC facility security clearance procedures to be completed. 1. Name: 2. Gender: 3. Date of Birth: 4. Place of birth (city, province, state, country): 5. Citizenship: 6. Passport Number: 7. Date of Passport Issue: 8. Date of Passport Expiration: 9. Type of Visa: 10. U.S. Naturalization Number (if a naturalized citizen): PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 11. U.S. Naturalization Date (if a naturalized citizen): 12. Visitor’s Organization: 13. Organization Address: 14. Organization Telephone Number: 15. Visitor’s Position/Title within the Organization: This information will be transmitted to the CDC Security Office for approval. Visitors will be notified as soon as approval has been obtained. You may submit comments, identified by CDC–2013–0010 and Docket Number NIOSH–265, by either of the following two methods: • Federal eRulemaking Portal: https:// www.regulations.gov. Follow the instructions for submitting comments. • Mail: NIOSH Docket Office, Robert A. Taft Laboratories, 4676 Columbia Parkway, MS C–34, Cincinnati, Ohio 45226. Instructions: All information received in response to this notice must include the agency name and docket number (CDC–2013–0010; NIOSH–265). All relevant comments received will be posted without change to https:// www.regulations.gov, including any personal information provided. All electronic comments should be formatted as Microsoft Word. Please make reference to CDC–2013–0010 and Docket Number NIOSH–265. SUPPLEMENTARY INFORMATION: Attendance: The meeting is open to the public, limited only by the capacity (80) of the conference room. Confirm your attendance to this meeting by sending an email to jun1@cdc.gov by July 17, 2013. An email confirming registration will be sent from NIOSH and will include details needed to participate. Oral comments given at the meeting will be recorded and included in the NIOSH Docket Number 265. Background: NIOSH is among the world’s leaders in promoting the safe and responsible development and use of ENMs. NIOSH has published guidelines on the safe use of ENMs including ‘‘Approaches to Safe Nanotechnology: Managing the Health and Safety Concerns Associated with Engineered Nanomaterials’’ (https://www.cdc.gov/ niosh/docs/2009–125/pdfs/2009– 125.pdf) and ‘‘General Safe Practices for Working With Engineered Nanomaterials in Research Laboratories’’ (https://www.cdc.gov/ niosh/docs/2012–147/pdfs/2012– 147.pdf). Other organizations in the U.S. and around the world have also developed guidelines for the safe use of ENMs. The proposed survey will examine the extent to which these and other guidelines are implemented and the barriers to using the guidelines. E:\FR\FM\19JNN1.SGM 19JNN1

Agencies

[Federal Register Volume 78, Number 118 (Wednesday, June 19, 2013)]
[Notices]
[Pages 36783-36784]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-14518]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Secretary's Advisory Committee on Human Research 
Protections

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Pursuant to Section 10(a) of the Federal Advisory Committee 
Act, U.S.C. Appendix 2, notice is hereby given that the Secretary's 
Advisory Committee on Human Research Protections (SACHRP) will hold a 
meeting that will be open to the public. Information about SACHRP and 
the full meeting agenda will be posted on the SACHRP Web site at: 
https://www.dhhs.gov/ohrp/sachrp/mtgings/.

DATES: The meeting will be held on Wednesday, July 10, 2013 from 8:30 
a.m. until 5:00 p.m. and Thursday, July 11, 2013 from 8:30 a.m. until 
4:30 p.m.

ADDRESSES: U.S. Department of Health and Human Services, 200 
Independence Avenue SW., Hubert H. Humphrey Building, Room 800, 
Washington, DC 20201.

FOR FUTHER INFORMATION CONTACT: Jerry Menikoff, M.D., J.D., Director, 
Office for Human Research Protections (OHRP), or Julia Gorey, J.D., 
Executive Director, SACHRP; U.S. Department of Health and Human 
Services, 1101 Wootton Parkway, Suite 200, Rockville, Maryland 20852; 
240-453-8141; fax: 240-453-6909; email address: Julia.Gorey@hhs.gov.

SUPPLEMENTARY INFORMATION: Under the authority of 42 U.S.C. 217a, 
Section 222 of the Public Health Service Act, as amended, SACHRP was 
established to provide expert advice and recommendations to the 
Secretary of Health and Human Services through the Assistant Secretary 
for Health, on issues and topics pertaining to or associated with the 
protection of human research subjects.
    The meeting will open to the public at 8:30 a.m., Wednesday, July 
10. Following opening remarks from Dr. Jerry Menikoff, OHRP Director, 
and Dr. Jeffrey Botkin, SACHRP Chair, the Subcommittee on Harmonization 
(SOH) will give their report. SOH was established by SACHRP at its July 
2009 meeting and is charged with identifying and prioritizing areas in 
which regulations and/or guidelines for human subjects research adopted 
by various agencies or offices within HHS would benefit from 
harmonization, consistency, clarity, simplification and/or 
coordination. The SOH report will be followed by an expert panel 
discussion

[[Page 36784]]

of informed consent issues in cluster randomized trials. After lunch, 
there will be a special expert panel discussing Certificates of 
Confidentiality (COCs).
    Following opening remarks on the morning of July 11, the Subpart A 
Subcommittee (SAS) will give their report. This will be followed by a 
discussion of the concept of engagement in human subjects research. SAS 
is charged with developing recommendations for consideration by SACHRP 
regarding the application of subpart A of 45 CFR part 46 in the current 
research environment; this Subcommittee was established by SACHRP in 
October 2006. The day will conclude with a panel discussion of issues 
surrounding electronic informed consent.
    Public attendance at the meeting is limited to space available. 
Individuals who plan to attend the meeting and need special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should notify the designated contact persons. Members 
of the public will have the opportunity to provide comments on both 
days of the meeting. Public comment will be limited to five minutes per 
speaker. Any members of the public who wish to have printed materials 
distributed to SACHRP members for this scheduled meeting should submit 
materials to the Executive Director, SACHRP, prior to the close of 
business July 5, 2013.

    Dated: June 12, 2013.
Jerry Menikoff,
Director, Office for Human Research Protections, Executive Secretary, 
Secretary's Advisory Committee on Human Research Protections.
[FR Doc. 2013-14518 Filed 6-18-13; 8:45 am]
BILLING CODE 4150-36-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.